Rare diseases
Investigational molecules
Locations
Study on Long-Term Safety and Efficacy of Ocrelizumab for Patients with Multiple Sclerosis
AustriaStudy on the Effectiveness and Safety of Batoclimab for Adults with Generalized Myasthenia Gravis
GermanyStudy on the Effectiveness and Safety of Iptacopan for Patients with Complement 3 Glomerulopathy
FranceStudy on the Safety and Efficacy of Linsitinib for Patients with Active, Moderate to Severe Thyroid Eye Disease
ItalyStudy of AMG 193 and IDE397 for Adults with Advanced MTAP-null Solid Tumors and Non-Small Cell Lung Cancer
DenmarkStudy on Ofatumumab for Patients with Relapsing Multiple Sclerosis Transitioning from Fumarate-Based Therapies or Fingolimod
BulgariaStudy on the Safety and Effectiveness of AUTO1 for Adults with Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia Using a Drug Combination
SpainStudy on the Safety and Effectiveness of Sunvozertinib for Patients with Advanced Non-Small Cell Lung Cancer with EGFR or HER2 Mutations
FranceStudy on Atezolizumab and Drug Combinations for Advanced Malignancies in Patients from Previous Atezolizumab Trials
BelgiumStudy on the Effectiveness and Safety of Ianalumab for Patients with Active Sjögren’s Syndrome
AustriaComparison of nilotinib versus imatinib treatment in newly diagnosed chronic myeloid leukemia patients to achieve treatment-free remission
ItalyStudy on the Long-term Effects of Dupilumab in Preventing Lung Function Decline in Adults with Uncontrolled Moderate to Severe Asthma
BelgiumTell us about your condition – we search every trial in Europe and connect you with the right site.
